Nordea Fourth-quarter and full-year results 2023
Delivery Hero announces preliminary results for Q4 2023 delivering ...
Delivery Hero SE announces preliminary Q4 2023 numbers early ...
Astanga Chikitsa: Swamy Raj Vibhu's Groundbreaking Approach to ...
SoftwareOne Founding Shareholders request the convening of an ...
Xlife Sciences AG Expands Collaboration with Department of Health ...
Yandex N.V. Announces Binding Agreement to Divest its Russia-based ...
RENK Group AG: Private Placement of shares of RENK Group AG from ...
L&T Technology Services Supports Marelli in Revolutionizing Automotive ...
Saudi Sports for All Federation Announces New Kingdom Arena Location ...
JCB and Tokyo Metro to launch special gift promotion for JCB ...
Fideum: Bridging Traditional Finance and Web3; Partnership with ...
Merck Foundation Marks World Cancer Day by Increasing the Limited ...
USISPF Welcomes Joe Ucuzoglu Raj Shah Alex Rogers and Prashant ...
Belkin Introduces Future Ventures Division for Further Product ...
Clinique Partners with Icahn School of Medicine at Mount Sinai ...
Located in Seoul Korea Topcon Korea Medical Co. Ltd. Was Established ...
Redcare Pharmacy N.V.: Preliminary announcement of the publication ...
HelloFresh SE: DSR Ventures GmbH Pledge of 500 000 and 110 000 ...
ENCAVIS AG: Release according to Article 40 Section 1 of the ...
Viromed Medical AG: Uwe Perbandt, buy
Viromed Medical AG: Uwe Perbandt, buy
Viromed Medical AG: Uwe Perbandt, buy
Viromed Medical AG: Uwe Perbandt, buy
Viromed Medical AG: Uwe Perbandt, buy
Viromed Medical AG: Uwe Perbandt, buy
Viromed Medical AG: Uwe Perbandt, buy
Viromed Medical AG: Uwe Perbandt, buy
EQS-CMS: Commerzbank Aktiengesellschaft: status share buyback ...
EQS-CMS: BP p.l.c.: Release of a capital market information
LION E-Mobility AG: Extraordinary General Meeting to resolve ...
Viromed Medical AG: Perbamed Invest GmbH, buy
Viromed Medical AG: Perbamed Invest GmbH, buy
Viromed Medical AG: Perbamed Invest GmbH, buy
Viromed Medical AG: Perbamed Invest GmbH, buy
Auto1 Group SE: Release according to Article 40 Section 1 of ...